Vanda Pharmaceuticals (VNDA) Cash & Current Investments (2010 - 2026)
Vanda Pharmaceuticals' Cash & Current Investments was $170.03 million in Q2 2026, down 47.8% from $325.55 million a year earlier and down 16.0% from the prior quarter.
Powered by 
Analysis
Vanda Pharmaceuticals (VNDA) Cash & Current Investments (2010 - 2026) Analysis & Trends
At the end of FY2025, Cash & Current Investments at Vanda Pharmaceuticals came in at $263.85 million, down 29.6% from FY2024.
- Cash & Current Investments has now declined for three consecutive years, with a five-year compound annual growth rate of -6.4% (FY2020 to FY2025).
- In earlier years, Cash & Current Investments was $374.64 million in FY2024 (-3.5%), $388.26 million in FY2023 (-16.8%), $466.86 million in FY2022 (+7.9%) and $432.81 million in FY2021 (+17.7%).
- The Q2 2026 figure marks the lowest quarterly Cash & Current Investments since Q4 2017.
- Compared with a year earlier, Cash & Current Investments has declined for 11 straight quarters, with an average decline of 24.5% over the last eight quarters.
- The best year-over-year quarter for Cash & Current Investments over five years was Q4 2021 (growth of 17.7%); the worst was Q2 2026 (a decline of 47.8%).
- Per Business Quant data, VNDA's Cash & Current Investments in the three quarters before Q2 2026 was $202.31 million (Q1 2026), $263.85 million (Q4 2025) and $293.75 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.76 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 7.14 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 9.92 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.97 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 11.70 Bn |
| 10 | Vanda Pharmaceuticals | 279.91 Mn | -650.03 Mn | 46.97 Mn | 170.03 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 170.03 Mn |
| Mar 31, 2026 | 202.31 Mn |
| Dec 31, 2025 | 263.85 Mn |
| Sep 30, 2025 | 293.75 Mn |
| Jun 30, 2025 | 325.55 Mn |
| Mar 31, 2025 | 340.91 Mn |
| Dec 31, 2024 | 374.64 Mn |
| Sep 30, 2024 | 376.26 Mn |
| Jun 30, 2024 | 387.68 Mn |
| Mar 31, 2024 | 394.14 Mn |
| Dec 31, 2023 | 388.26 Mn |
| Sep 30, 2023 | 489.86 Mn |
| Jun 30, 2023 | 489.35 Mn |
| Mar 31, 2023 | 501.50 Mn |
| Dec 31, 2022 | 466.86 Mn |
| Sep 30, 2022 | 454.79 Mn |
| Jun 30, 2022 | 440.86 Mn |
| Mar 31, 2022 | 435.18 Mn |
| Dec 31, 2021 | 432.81 Mn |
| Sep 30, 2021 | 405.97 Mn |
API Access
Vanda Pharmaceuticals Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=VNDA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "VNDA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=VNDA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();